Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.

Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.

Item
http://www.wikidata.org/entity/Q35102747
Resistance of M. leprae to quinolones: a question of relativity?Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococciNew advances in antibiotic development and discovery.Investigational new drugs for the treatment of resistant pneumococcal infections.Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.Mutant selection window hypothesis updated.Antimicrobial resistance and the management of anaerobic infections.Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.Garenoxacin pharmacokinetics in patients undergoing maintenance hemodialysis.Garenoxacin in Skin and Skin Structure Infections Sustained due to Road Traffic Accident.Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.Evolving therapy for Helicobacter pylori infection
P2860

Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.

Item
http://www.wikidata.org/entity/Q35102747
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@ast
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@en
type
label
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@ast
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@en
prefLabel
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@ast
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.47.7.2256-2263.2003
P407
P433
P478
P577
P698
P932